The Active Care Group shortlisted for Health Investor Awards 2020

The Active Care Group shortlisted for Health Investor Awards 2020

13th May 2020 May 15th, 2020

The Active Care Group (ACG) and its entities within the structure have been nominated in four categories at this years Health Investor Awards, one of the most prestigious in the health and social care sector. The awards recognise the outstanding achievements and contributions of staff, companies and investors.

ACG have been shortlisted for Specialist Care Provider of the Year & Complex Care Provider of the Year. Christchurch Group has been shortlisted for Complex Care Provider of the Year while Neural Pathways has been shortlisted in the Community Support Provider of the Year category. Jane Lewis Healthcare, part of the staffing division at ACG, has been shortlisted for Recruiter of the Year.

This follows a successful year for the group where they had numerous nominations and award wins.

Oliver Harris, Montreux Capital Management UK CEO said, “This has been a great start to year for the Active Care Group, so it’s pleasing to see acknowledgement of their hard work and commitment. Best of luck to all involved.”

Full details of shortlisted finalists can be found here on the Health Investor website.

https://www.ipevents.net/healthinvestorawards/finalists2020/

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT